Firibastat in Treatment-resistant Hypertension
Public ClinicalTrials.gov record NCT04277884. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double-blind, Placebo-controlled, Efficacy and Safety Study of Firibastat (QGC001) Administered Orally, Twice Daily, Over 12 Weeks in Difficult-to-treat/Resistant Hypertensive Subjects
Study identification
- NCT ID
- NCT04277884
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Quantum Genomics SA
- Industry
- Enrollment
- 515 participants
Conditions and interventions
Conditions
Interventions
- Firibastat Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 24, 2020
- Primary completion
- Aug 29, 2022
- Completion
- Sep 19, 2022
- Last update posted
- Oct 19, 2022
2020 – 2022
United States locations
- U.S. sites
- 15
- U.S. states
- 8
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Alabama Research | Birmingham | Alabama | 35209-8401 | — |
| Marvel Clinical Research | Huntington Beach | California | 92647 | — |
| Orange County Research Center | Tustin | California | 92780 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Cardiovascular Center of Sarasota | Sarasota | Florida | 34239 | — |
| Apex Medical Research | Chicago | Illinois | 60607 | — |
| Cedar Crosse Research Center | Chicago | Illinois | 60607 | — |
| ClinEdge - Chear Center | The Bronx | New York | 10455 | — |
| Sterling Research Group - Cincinnati / Mount Auburn | Cincinnati | Ohio | 45219 | — |
| Insearch - Punzi Medical Center | Carrollton | Texas | 75006 | — |
| ClinEdge - Dayton Clinical Research | Dayton | Texas | 45406-5144 | — |
| Juno Research - Corporate Office | Houston | Texas | 77040 | — |
| Insearch - R&H Clinical Research | Katy | Texas | 77450 | — |
| Manassas Clinical Research Center | Manassas | Virginia | 20110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04277884, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 19, 2022 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04277884 live on ClinicalTrials.gov.